33
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Warfarin sodium is widely used and causes bleeding; a review might suggest the need for regulatory action by the US Food and Drug Administration (FDA).

          Related collections

          Author and article information

          Journal
          Arch Intern Med
          Archives of internal medicine
          American Medical Association (AMA)
          0003-9926
          0003-9926
          Jul 09 2007
          : 167
          : 13
          Affiliations
          [1 ] Division of Drug Risk Evaluation, Food and Drug Administration, White Oak, Bldg 22, Room 3424, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA. diane.wysowski@fda.hhs.gov
          Article
          167/13/1414
          10.1001/archinte.167.13.1414
          17620536
          3f050878-74f2-492c-883f-ce331dd0a035
          History

          Comments

          Comment on this article